nodes	percent_of_prediction	percent_of_DWPC	metapath
Methimazole—CYP2B6—malignant glioma	0.664	1	CbGaD
Methimazole—CYP1A2—Carmustine—malignant glioma	0.125	0.57	CbGbCtD
Methimazole—CYP3A4—Temozolomide—malignant glioma	0.0947	0.43	CbGbCtD
Methimazole—Pigmentation disorder—Temozolomide—malignant glioma	0.000371	0.189	CcSEcCtD
Methimazole—Aplastic anaemia—Temozolomide—malignant glioma	0.000116	0.0592	CcSEcCtD
Methimazole—Neuropathy peripheral—Carmustine—malignant glioma	7.03e-05	0.0358	CcSEcCtD
Methimazole—Neuropathy peripheral—Temozolomide—malignant glioma	6.8e-05	0.0346	CcSEcCtD
Methimazole—Hepatitis—Temozolomide—malignant glioma	6.23e-05	0.0317	CcSEcCtD
Methimazole—Alopecia—Carmustine—malignant glioma	5.69e-05	0.029	CcSEcCtD
Methimazole—Alopecia—Temozolomide—malignant glioma	5.5e-05	0.028	CcSEcCtD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	5.07e-05	0.000445	CbGpPWpGaD
Methimazole—Leukopenia—Carmustine—malignant glioma	5.02e-05	0.0255	CcSEcCtD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	4.96e-05	0.000436	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	4.96e-05	0.000436	CbGpPWpGaD
Methimazole—CYP3A4—Biological oxidations—PTGS1—malignant glioma	4.91e-05	0.000431	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—ASMT—malignant glioma	4.89e-05	0.000429	CbGpPWpGaD
Methimazole—Vertigo—Temozolomide—malignant glioma	4.87e-05	0.0248	CcSEcCtD
Methimazole—Leukopenia—Temozolomide—malignant glioma	4.85e-05	0.0247	CcSEcCtD
Methimazole—Myalgia—Carmustine—malignant glioma	4.77e-05	0.0243	CcSEcCtD
Methimazole—TPO—Metabolism—PIK3CG—malignant glioma	4.76e-05	0.000418	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—RTEL1—malignant glioma	4.75e-05	0.000418	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	4.72e-05	0.000415	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	4.72e-05	0.000415	CbGpPWpGaD
Methimazole—CYP1A2—Biological oxidations—GSTP1—malignant glioma	4.7e-05	0.000413	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	4.69e-05	0.000411	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—COX8A—malignant glioma	4.64e-05	0.000407	CbGpPWpGaD
Methimazole—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	4.64e-05	0.000407	CbGpPWpGaD
Methimazole—Arthralgia—Temozolomide—malignant glioma	4.61e-05	0.0235	CcSEcCtD
Methimazole—Myalgia—Temozolomide—malignant glioma	4.61e-05	0.0235	CcSEcCtD
Methimazole—CYP2A6—Metabolism—BCAN—malignant glioma	4.6e-05	0.000404	CbGpPWpGaD
Methimazole—TPO—Metabolism—PPARG—malignant glioma	4.6e-05	0.000404	CbGpPWpGaD
Methimazole—Oedema—Carmustine—malignant glioma	4.58e-05	0.0233	CcSEcCtD
Methimazole—CYP2E1—Metabolism—COX8A—malignant glioma	4.54e-05	0.000399	CbGpPWpGaD
Methimazole—Thrombocytopenia—Carmustine—malignant glioma	4.48e-05	0.0228	CcSEcCtD
Methimazole—Oedema—Temozolomide—malignant glioma	4.42e-05	0.0225	CcSEcCtD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	4.36e-05	0.000383	CbGpPWpGaD
Methimazole—Thrombocytopenia—Temozolomide—malignant glioma	4.33e-05	0.022	CcSEcCtD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	4.22e-05	0.000371	CbGpPWpGaD
Methimazole—TPO—Metabolism—PIK3CD—malignant glioma	4.19e-05	0.000368	CbGpPWpGaD
Methimazole—Musculoskeletal discomfort—Carmustine—malignant glioma	4.17e-05	0.0212	CcSEcCtD
Methimazole—Paraesthesia—Carmustine—malignant glioma	4.11e-05	0.0209	CcSEcCtD
Methimazole—Somnolence—Carmustine—malignant glioma	4.07e-05	0.0207	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Temozolomide—malignant glioma	4.03e-05	0.0205	CcSEcCtD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	3.98e-05	0.000349	CbGpPWpGaD
Methimazole—Paraesthesia—Temozolomide—malignant glioma	3.97e-05	0.0202	CcSEcCtD
Methimazole—CYP2B6—Metabolism—ASMT—malignant glioma	3.94e-05	0.000346	CbGpPWpGaD
Methimazole—Somnolence—Temozolomide—malignant glioma	3.93e-05	0.02	CcSEcCtD
Methimazole—Dyspepsia—Temozolomide—malignant glioma	3.89e-05	0.0198	CcSEcCtD
Methimazole—CYP2E1—Metabolism—ASMT—malignant glioma	3.86e-05	0.000339	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	3.85e-05	0.000338	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—BCAN—malignant glioma	3.71e-05	0.000326	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—IDH2—malignant glioma	3.7e-05	0.000325	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—RTEL1—malignant glioma	3.67e-05	0.000322	CbGpPWpGaD
Methimazole—TPO—Metabolism—PIK3CB—malignant glioma	3.65e-05	0.00032	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—BCAN—malignant glioma	3.63e-05	0.000319	CbGpPWpGaD
Methimazole—CYP3A4—Biological oxidations—GSTP1—malignant glioma	3.63e-05	0.000319	CbGpPWpGaD
Methimazole—Body temperature increased—Carmustine—malignant glioma	3.62e-05	0.0184	CcSEcCtD
Methimazole—TPO—Metabolism—PTGS2—malignant glioma	3.61e-05	0.000317	CbGpPWpGaD
Methimazole—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	3.58e-05	0.000314	CbGpPWpGaD
Methimazole—Urticaria—Temozolomide—malignant glioma	3.51e-05	0.0179	CcSEcCtD
Methimazole—CYP2C19—Metabolism—COX8A—malignant glioma	3.5e-05	0.000308	CbGpPWpGaD
Methimazole—Body temperature increased—Temozolomide—malignant glioma	3.5e-05	0.0178	CcSEcCtD
Methimazole—CYP2A6—Metabolism—CYP2B6—malignant glioma	3.48e-05	0.000306	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	3.4e-05	0.000298	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	3.29e-05	0.000289	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—COX8A—malignant glioma	3.22e-05	0.000283	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—COX8A—malignant glioma	3.2e-05	0.000281	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—IDH1—malignant glioma	3.19e-05	0.00028	CbGpPWpGaD
Methimazole—TPO—Metabolism—PTEN—malignant glioma	3.15e-05	0.000277	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.13e-05	0.000275	CbGpPWpGaD
Methimazole—Pruritus—Temozolomide—malignant glioma	3.13e-05	0.0159	CcSEcCtD
Methimazole—CYP2A6—Metabolism—SPHK1—malignant glioma	3.08e-05	0.000271	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—CYP2C18—malignant glioma	3.02e-05	0.000265	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—IDH2—malignant glioma	2.99e-05	0.000262	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ASMT—malignant glioma	2.98e-05	0.000262	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—IDH2—malignant glioma	2.93e-05	0.000257	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.91e-05	0.000256	CbGpPWpGaD
Methimazole—Vomiting—Carmustine—malignant glioma	2.91e-05	0.0148	CcSEcCtD
Methimazole—Rash—Carmustine—malignant glioma	2.89e-05	0.0147	CcSEcCtD
Methimazole—Dermatitis—Carmustine—malignant glioma	2.88e-05	0.0147	CcSEcCtD
Methimazole—Headache—Carmustine—malignant glioma	2.87e-05	0.0146	CcSEcCtD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.86e-05	0.000251	CbGpPWpGaD
Methimazole—Vomiting—Temozolomide—malignant glioma	2.81e-05	0.0143	CcSEcCtD
Methimazole—CYP2C19—Metabolism—BCAN—malignant glioma	2.8e-05	0.000246	CbGpPWpGaD
Methimazole—Rash—Temozolomide—malignant glioma	2.79e-05	0.0142	CcSEcCtD
Methimazole—Dermatitis—Temozolomide—malignant glioma	2.79e-05	0.0142	CcSEcCtD
Methimazole—Headache—Temozolomide—malignant glioma	2.77e-05	0.0141	CcSEcCtD
Methimazole—CYP2E1—Metabolism—CYP2B6—malignant glioma	2.75e-05	0.000242	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ASMT—malignant glioma	2.74e-05	0.000241	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—COX8A—malignant glioma	2.73e-05	0.00024	CbGpPWpGaD
Methimazole—Nausea—Carmustine—malignant glioma	2.72e-05	0.0138	CcSEcCtD
Methimazole—CYP2C9—Metabolism—ASMT—malignant glioma	2.72e-05	0.000239	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.66e-05	0.000233	CbGpPWpGaD
Methimazole—Nausea—Temozolomide—malignant glioma	2.63e-05	0.0134	CcSEcCtD
Methimazole—CYP2D6—Metabolism—BCAN—malignant glioma	2.58e-05	0.000226	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—IDH1—malignant glioma	2.57e-05	0.000226	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—BCAN—malignant glioma	2.55e-05	0.000224	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—IDH1—malignant glioma	2.52e-05	0.000221	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—SPHK1—malignant glioma	2.49e-05	0.000218	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—GSTT1—malignant glioma	2.44e-05	0.000214	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.44e-05	0.000214	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CYP2C18—malignant glioma	2.44e-05	0.000214	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—SPHK1—malignant glioma	2.44e-05	0.000214	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CYP2C18—malignant glioma	2.39e-05	0.00021	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ASMT—malignant glioma	2.32e-05	0.000204	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PTGS1—malignant glioma	2.29e-05	0.000201	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.27e-05	0.000199	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—IDH2—malignant glioma	2.26e-05	0.000198	CbGpPWpGaD
Methimazole—TPO—Metabolism—PIK3CA—malignant glioma	2.22e-05	0.000195	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—BCAN—malignant glioma	2.18e-05	0.000192	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.13e-05	0.000187	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—BCHE—malignant glioma	2.13e-05	0.000187	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP2B6—malignant glioma	2.12e-05	0.000186	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—COX8A—malignant glioma	2.11e-05	0.000185	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—SLC5A5—malignant glioma	2.1e-05	0.000185	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—IDH2—malignant glioma	2.08e-05	0.000182	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—IDH2—malignant glioma	2.06e-05	0.000181	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GSTT1—malignant glioma	1.97e-05	0.000173	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP2B6—malignant glioma	1.95e-05	0.000172	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—IDH1—malignant glioma	1.94e-05	0.000171	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.94e-05	0.000171	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP2B6—malignant glioma	1.94e-05	0.00017	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GSTT1—malignant glioma	1.93e-05	0.000169	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—SPHK1—malignant glioma	1.88e-05	0.000165	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PTGS1—malignant glioma	1.85e-05	0.000162	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP2C18—malignant glioma	1.84e-05	0.000162	CbGpPWpGaD
Methimazole—TPO—Metabolism—AKT1—malignant glioma	1.82e-05	0.00016	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PTGS1—malignant glioma	1.81e-05	0.000159	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ASMT—malignant glioma	1.79e-05	0.000157	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—IDH1—malignant glioma	1.79e-05	0.000157	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—IDH1—malignant glioma	1.77e-05	0.000156	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—IDH2—malignant glioma	1.76e-05	0.000155	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.74e-05	0.000152	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—SPHK1—malignant glioma	1.73e-05	0.000152	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—BCHE—malignant glioma	1.72e-05	0.000151	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—SPHK1—malignant glioma	1.71e-05	0.00015	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—SLC5A5—malignant glioma	1.7e-05	0.000149	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.69e-05	0.000149	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—GSTP1—malignant glioma	1.69e-05	0.000149	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—BCAN—malignant glioma	1.68e-05	0.000148	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—BCHE—malignant glioma	1.68e-05	0.000148	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.68e-05	0.000147	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—SLC5A5—malignant glioma	1.66e-05	0.000146	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.66e-05	0.000146	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP2B6—malignant glioma	1.65e-05	0.000145	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—CAT—malignant glioma	1.65e-05	0.000145	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.58e-05	0.000139	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.58e-05	0.000139	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—NCOR1—malignant glioma	1.56e-05	0.000137	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.53e-05	0.000134	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—IDH1—malignant glioma	1.51e-05	0.000133	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GSTT1—malignant glioma	1.49e-05	0.000131	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SPHK1—malignant glioma	1.46e-05	0.000129	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.44e-05	0.000127	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP2C18—malignant glioma	1.43e-05	0.000126	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PTGS1—malignant glioma	1.4e-05	0.000123	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.39e-05	0.000122	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.39e-05	0.000122	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GSTT1—malignant glioma	1.37e-05	0.00012	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GSTP1—malignant glioma	1.37e-05	0.00012	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—IDH2—malignant glioma	1.36e-05	0.000119	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GSTT1—malignant glioma	1.36e-05	0.000119	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.35e-05	0.000119	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GSTP1—malignant glioma	1.34e-05	0.000117	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CAT—malignant glioma	1.33e-05	0.000117	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CAT—malignant glioma	1.3e-05	0.000114	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—BCHE—malignant glioma	1.3e-05	0.000114	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PTGS1—malignant glioma	1.28e-05	0.000113	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—SLC5A5—malignant glioma	1.28e-05	0.000113	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.28e-05	0.000112	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PTGS1—malignant glioma	1.27e-05	0.000112	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—CAV1—malignant glioma	1.27e-05	0.000111	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.27e-05	0.000111	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—NCOR1—malignant glioma	1.26e-05	0.00011	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.23e-05	0.000108	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—NCOR1—malignant glioma	1.23e-05	0.000108	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.21e-05	0.000106	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.2e-05	0.000105	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—BCHE—malignant glioma	1.19e-05	0.000105	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.19e-05	0.000104	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—BCHE—malignant glioma	1.18e-05	0.000104	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—SLC5A5—malignant glioma	1.18e-05	0.000103	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.17e-05	0.000103	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—IDH1—malignant glioma	1.17e-05	0.000103	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTT1—malignant glioma	1.16e-05	0.000102	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CG—malignant glioma	1.16e-05	0.000101	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SPHK1—malignant glioma	1.13e-05	9.92e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PPARG—malignant glioma	1.11e-05	9.79e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.11e-05	9.72e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.1e-05	9.7e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.09e-05	9.61e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PTGS1—malignant glioma	1.09e-05	9.55e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.08e-05	9.51e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.05e-05	9.19e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GSTP1—malignant glioma	1.03e-05	9.06e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CAV1—malignant glioma	1.02e-05	8.98e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CD—malignant glioma	1.02e-05	8.92e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—BCHE—malignant glioma	1.01e-05	8.88e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CAT—malignant glioma	1e-05	8.82e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CAV1—malignant glioma	1e-05	8.8e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SLC5A5—malignant glioma	9.98e-06	8.77e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.55e-06	8.38e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GSTP1—malignant glioma	9.49e-06	8.34e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—NCOR1—malignant glioma	9.48e-06	8.33e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.44e-06	8.29e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GSTP1—malignant glioma	9.41e-06	8.26e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.35e-06	8.21e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CG—malignant glioma	9.32e-06	8.18e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CAT—malignant glioma	9.24e-06	8.11e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CAT—malignant glioma	9.16e-06	8.04e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CG—malignant glioma	9.13e-06	8.02e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PPARG—malignant glioma	8.99e-06	7.9e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTT1—malignant glioma	8.95e-06	7.86e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CB—malignant glioma	8.85e-06	7.77e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PPARG—malignant glioma	8.81e-06	7.74e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PTGS2—malignant glioma	8.77e-06	7.7e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—NCOR1—malignant glioma	8.72e-06	7.66e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—NCOR1—malignant glioma	8.65e-06	7.59e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PTGS1—malignant glioma	8.39e-06	7.37e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CD—malignant glioma	8.19e-06	7.19e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.16e-06	7.16e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTP1—malignant glioma	8.04e-06	7.06e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CD—malignant glioma	8.02e-06	7.05e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CAT—malignant glioma	7.83e-06	6.87e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—BCHE—malignant glioma	7.8e-06	6.85e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CAV1—malignant glioma	7.73e-06	6.79e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SLC5A5—malignant glioma	7.7e-06	6.77e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PTEN—malignant glioma	7.65e-06	6.72e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NCOR1—malignant glioma	7.39e-06	6.49e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.39e-06	6.49e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CB—malignant glioma	7.14e-06	6.27e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CAV1—malignant glioma	7.11e-06	6.24e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PTGS2—malignant glioma	7.08e-06	6.21e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CAV1—malignant glioma	7.05e-06	6.19e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CG—malignant glioma	7.04e-06	6.18e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CB—malignant glioma	6.99e-06	6.14e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PTGS2—malignant glioma	6.93e-06	6.09e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PPARG—malignant glioma	6.8e-06	5.97e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.74e-06	5.91e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CG—malignant glioma	6.48e-06	5.69e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CG—malignant glioma	6.42e-06	5.64e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PPARG—malignant glioma	6.25e-06	5.49e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTP1—malignant glioma	6.21e-06	5.45e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PPARG—malignant glioma	6.2e-06	5.44e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CD—malignant glioma	6.19e-06	5.44e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PTEN—malignant glioma	6.17e-06	5.42e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PTEN—malignant glioma	6.04e-06	5.31e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CAT—malignant glioma	6.04e-06	5.3e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CAV1—malignant glioma	6.02e-06	5.29e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.76e-06	5.05e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NCOR1—malignant glioma	5.7e-06	5.01e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CD—malignant glioma	5.69e-06	5e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CD—malignant glioma	5.64e-06	4.96e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CG—malignant glioma	5.49e-06	4.82e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CB—malignant glioma	5.4e-06	4.74e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CA—malignant glioma	5.4e-06	4.74e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PTGS2—malignant glioma	5.35e-06	4.7e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PPARG—malignant glioma	5.3e-06	4.65e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CB—malignant glioma	4.96e-06	4.36e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CB—malignant glioma	4.92e-06	4.32e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PTGS2—malignant glioma	4.92e-06	4.32e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PTGS2—malignant glioma	4.88e-06	4.28e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CD—malignant glioma	4.82e-06	4.24e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PTEN—malignant glioma	4.66e-06	4.09e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CAV1—malignant glioma	4.65e-06	4.08e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—AKT1—malignant glioma	4.41e-06	3.87e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CA—malignant glioma	4.35e-06	3.82e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PTEN—malignant glioma	4.29e-06	3.77e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CA—malignant glioma	4.26e-06	3.74e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PTEN—malignant glioma	4.25e-06	3.73e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CG—malignant glioma	4.23e-06	3.72e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CB—malignant glioma	4.2e-06	3.69e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PTGS2—malignant glioma	4.17e-06	3.66e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PPARG—malignant glioma	4.09e-06	3.59e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.72e-06	3.27e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PTEN—malignant glioma	3.63e-06	3.19e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—AKT1—malignant glioma	3.56e-06	3.12e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—AKT1—malignant glioma	3.48e-06	3.06e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CA—malignant glioma	3.29e-06	2.89e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.24e-06	2.85e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PTGS2—malignant glioma	3.22e-06	2.82e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CA—malignant glioma	3.03e-06	2.66e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CA—malignant glioma	3e-06	2.63e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PTEN—malignant glioma	2.8e-06	2.46e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—AKT1—malignant glioma	2.69e-06	2.36e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CA—malignant glioma	2.56e-06	2.25e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—AKT1—malignant glioma	2.47e-06	2.17e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—AKT1—malignant glioma	2.45e-06	2.15e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—AKT1—malignant glioma	2.09e-06	1.84e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.98e-06	1.74e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—AKT1—malignant glioma	1.62e-06	1.42e-05	CbGpPWpGaD
